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Due to its anti-inﬂammatory and immunosuppressive potential,
Nitric oxide (NO), a gaseous radical, is of special importance
during graft-versus-host diseases (GVHD) and feoto-maternal
tolerance. NO is a major mediator of murine mesenchymal stro-
mal cells (MSCs)-immunosuppressive capacity. In this data arti-
cle, we characterized NO production by human bone marrow-
derived MSCs (hBMSCs). MSCs, isolated from healthy donors
(n¼5), were deﬁned according to the International Society for
cellular Therapy (ISCT) guidelines. Based on a ﬂuorometric
detection system, and upon using Nitrite (NO2 )/Nitrate ( NO

3 )
Assay Kit, the amounts of NO metabolites ( NO2 and NO

3 )
produced by hBMSCs, being grown in a culture medium either
lacking (constitutive condition) or containing IL-4, IL-10 or a pro-
inﬂammatory cytokine cocktail made of IL-1β, TNF-α, IFN-α and
IFN-γ, were assessed. All assays were carried out in triplicates
and the mean values are reported. The data from this study
supports and corroborates the discussion associated with our
previously published work entitled “The Immunomodulatoryis an open access article under the CC BY license
Therapy, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Campus
e de Lennik no 808, 1070 Brussels, Belgium. Fax: þ00 32 2 5556624.
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M. Najar et al. / Data in Brief 8 (2016) 1111–11141112Potential of Mesenchymal Stromal Cells: A Story of a Regulatory
Network” (Najar et al., 2016) [1].
& 2016 Published by Elsevier Inc. This is an open access article
under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaMesenchymal stromal cells (MSCs)ype of data Figure
ow data was
acquiredFluorometric detection of nitric oxide metabolitesata format Analyzed
xperimental
factorshBMSCs were cultured under basic state or treated with IL-4 (50 ng/ml), IL-
10 (50 ng/ml) or a pro-inﬂammatory cytokine cocktail containing IL-1β (25
ng/ml), TNF-α (50 ng/ml), IFN-α (10 ng/ml) and IFN-γ (50 ng/ml)xperimental
featuresNO2 and NO3 production levels by hBMSCs were assessed using the Nitrite/
Nitrate Assay Kit (Sigma)ata source
locationInstitut Jules Bordet, Brussels, Belgiumata accessibility Data are provided in the paperD
Value of the data
 This data provides evidences that NO is not constitutively produced by hBMSCs
 This data will be beneﬁcial for the scientiﬁc community focusing on understanding the molecular
mechanisms by which hBMSCs modulate the function of their target cells
 This data could help to understand the varied therapeutic efﬁciency exhibited by MSCs-derived
from different organisms.1. Data
The data presented here show Nitrite ( NO2 ) (Fig. 1, Panel A) and Nitrate ( NO

3 ) (Fig. 1, Panel B)
concentrations detected in the culture media after cultivating hBMSCs in the absence or presence of
IL-4, IL-10 or a pro-inﬂammatory cytokine cocktail containing IL-1β, TNF-α, IFN-α and IFN-γ.2. Experimental design, materials and methods
2.1. Isolation and cultivation of hBMSCs
This study was conducted in accordance with the Declaration of Helsinki (1964) and after approval
of the ethics committee of the “Institut Jules Bordet” (Belgium). BM was obtained either from the
sternum or iliac crest of healthy donors (n¼5). Informed written consent is obtained from each donor.
Brieﬂy, mononuclear cells (MNCs) were isolated from bone barrow aspirates by density-gradient
centrifugation (LinfoSep, Biomedics, Madrid, Spain) and then washed in Hanks' Balanced Salt Solution
(HBSS, Lonza Europe, Verviers, Belgium). MNCs were seeded at 2104 cells/cm2 in low glucose
Dulbecco's Modiﬁed Eagle's Medium (DMEM-LG, Lonza) supplemented with 15% fetal bovine serum
(FBS, Sigma-Aldrich, Bornem, Belgium), 2 mM L-glutamine and 50 U/ml penicillin (both from Lonza).
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Fig. 1. NO metabolite production by hBMSCs. hBMSCs were cultivated under both basic and cytokine primed conditions. Cell
priming was performed by treating cells (overnight) with IL-10, IL-4 or a pro-inﬂammatory cytokine cocktail (IL-1β, TNF-α, IFN-
α and IFN-γ). The supernatant of hBMSCs was collected and NO concentration was measured by determining NO2 and NO

3
levels upon following the guidelines provided by the Nitrite/Nitrate Assay Kit (Sigma). Values reported represent the Mean
concentration (mM) of NO2 (Panel A) and NO

3 (Panel B)7SD. Fresh culture medium lacking cells was used as a blank and
served as a control.
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80–90% conﬂuency, trypsinized (Lonza), centrifuged, and expanded by subculturing at a lower
density (1000 cells/cm2). MSCs were analyzed under both constitutive (control) and cytokine primed
conditions. Cell priming was carried out by treating cells (overnight) with IL-10 (50 ng/ml), IL-4
(50 ng/ml) or a pro-inﬂammatory cytokine cocktail containing IL-1β (Peprotech, Rocky Hill, NJ, USA)
(25 ng/ml), TNF-α (50 ng/ml), IFN-α (3000 U/ml or 10 ng/ml) and IFN-γ (1000 U/ml or 50 ng/ml)
(all from Prospec Inc., Rehovot, Israel).
2.2. NO detection
After culturing hBMSCs under the different conditions (basic versus cytokine primed), their
supernatants were collected by centrifugation where Nitrite (NO2 ) and Nitrate (NO

3 ) concentrations
were determined using the Nitrite/Nitrate Assay Kit (Sigma). Using this assay, ﬂuorometric detection
of Nitrite (NO2 ) concentration, in a sample, was achieved upon allowing a chemical reaction between
Nitrite (NO2 ) and 2,3-diaminonaphthalene (DAN) to generate a ﬂuorescent product called naph-
thotriazole. The ﬂuorescence intensity was read using a ﬂuorescence reader (FLUOstar Optima; BMG
Labtech, Ortenberg, Germany) with excitation/emission wave lengths of 360 nm/450 nm. For deter-
mination of Nitrate (NO3 ) concentration in a sample, NO

3 was ﬁrst converted to NO

2 by the enzyme
Nitrate Reductase, where the measured ﬂuorescence-intensity corresponds to the total [NO2 þNO3 ]
amount in the tested sample. Then, the previously measured [NO2 ] concentration was subtracted
from the obtained [NO2 þNO3 ] value. Accordingly, the Nitrate (NO3 ) concentration was calculated
according to the formula: [NO3 ]¼[NO2 þNO3 ][NO2 ]. Noteworthy that, [NO2 ] and [NO2 þ
NO3 ] values were determined using standard curves.
2.3. Statistical analysis
The data were analyzed with Optima software (BMG Labtech, Ortenberg, Germany). Three separate
experiments were carried out in triplicate and averaged. Data are presented as means 7 SD and
analyzed using Wilcoxon Signed Rank test. P-Valueso0.05 were considered signiﬁcant.Acknowledgments
We gratefully acknowledge the support received from the "Fonds de la Recherche Scientiﬁque
(FNRS), and its Télévie program.Transparency document. Supporting information
Transparency data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2016.07.021.Reference
[1] M. Najar, G. Raicevic, E. Crompot, H. Fayyad-Kazan, D. Bron, M. Toungouz, et al., The immunomodulatory potential of
mesenchymal stromal cells: a story of a regulatory network, J. Immunother. 39 (2016) 45–59.
